AustralieFrV1, Main, Exploration, bibRecord, 004E72

Inhaler competence in asthma: Common errors, barriers to use and recommended solutions

Identifieur interne : 004E72 ( Main/Exploration ); précédent : 004E71; suivant : 004E73

Inhaler competence in asthma: Common errors, barriers to use and recommended solutions

Auteurs : D. Price [Royaume-Uni] ; S. Bosnic-Anticevich [Australie] ; A. Briggs [Royaume-Uni] ; H. Chrystyn [Royaume-Uni] ; C. Rand [États-Unis] ; G. Scheuch [Allemagne] ; J. Bousquet [France]

Source :

Respiratory medicine [ 0954-6111 ] ; 2013.

RBID : Pascal:13-0060161

Descripteurs français

Pascal (Inist)
- Asthme, Bronchopneumopathie chronique obstructive, Bronchopneumopathie obstructive, Inhalateur, Erreur, Barrière, Solution, Chronique, Pneumologie.

English descriptors

KwdEn :
- Asthma, Barrier, Chronic, Chronic obstructive pulmonary disease, Error, Inhaler, Obstructive pulmonary disease, Pneumology, Solution.

Abstract

Whilst the inhaled route is the first line administration method in the management of asthma, it is well documented that patients can have problems adopting the correct inhaler technique and thus receiving adequate medication. This applies equally to metered dose inhalers and dry powder inhalers and leads to poor disease control and increased healthcare costs. Reviews have highlighted these problems and the recent European Consensus Statement developed a call to action to seek solutions. This review takes forward the challenge of inhaler competence by highlighting the issues and suggesting potential solutions to these problems. The opportunity for technological innovation and educational interventions to reduce errors is highlighted, as well as the specific challenges faced by children. This review is intended as a policy document, as most issues faced by patients have not changed for half a century, and this situation should not be allowed to continue any longer. Future direction with respect to research, policy needs and practice, together with education requirements in inhaler technique are described.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000C87
to stream PascalFrancis, to step Curation: 005177
to stream PascalFrancis, to step Checkpoint: 000867
to stream Main, to step Merge: 005041
to stream Main, to step Curation: 004E72

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Inhaler competence in asthma: Common errors, barriers to use and recommended solutions</title>
<author><name sortKey="Price, D" sort="Price, D" uniqKey="Price D" first="D." last="Price">D. Price</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Academic Primary Care, University of Aberdeen</s1>
<s2>Foresterhill, Aberdeen AB25 2ZD</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Foresterhill, Aberdeen AB25 2ZD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bosnic Anticevich, S" sort="Bosnic Anticevich, S" uniqKey="Bosnic Anticevich S" first="S." last="Bosnic-Anticevich">S. Bosnic-Anticevich</name>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Faculty of Pharmacy, The University of Sydney</s1>
<s2>Sydney, New South Wales</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
<author><name sortKey="Briggs, A" sort="Briggs, A" uniqKey="Briggs A" first="A." last="Briggs">A. Briggs</name>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Health Economics & Health Technology Assessment, University of Glasgow</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Glasgow</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université de Glasgow</orgName>
</affiliation>
</author>
<author><name sortKey="Chrystyn, H" sort="Chrystyn, H" uniqKey="Chrystyn H" first="H." last="Chrystyn">H. Chrystyn</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Division of Pharmacy and Pharmaceutical Sciences, University of Huddersfield</s1>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Division of Pharmacy and Pharmaceutical Sciences, University of Huddersfield</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rand, C" sort="Rand, C" uniqKey="Rand C" first="C." last="Rand">C. Rand</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Medicine, Johns Hopkins University</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Baltimore, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Scheuch, G" sort="Scheuch, G" uniqKey="Scheuch G" first="G." last="Scheuch">G. Scheuch</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Activoero GmbH</s1>
<s2>Gemünden</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Gemünden</wicri:noRegion>
<wicri:noRegion>Activoero GmbH</wicri:noRegion>
<wicri:noRegion>Activoero GmbH</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bousquet, J" sort="Bousquet, J" uniqKey="Bousquet J" first="J." last="Bousquet">J. Bousquet</name>
<affiliation wicri:level="3"><inist:fA14 i1="07"><s1>Hôpital Arnaud de Villeneuve</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0060161</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0060161 INIST</idno>
<idno type="RBID">Pascal:13-0060161</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C87</idno>
<idno type="wicri:Area/PascalFrancis/Curation">005177</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000867</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000867</idno>
<idno type="wicri:doubleKey">0954-6111:2013:Price D:inhaler:competence:in</idno>
<idno type="wicri:Area/Main/Merge">005041</idno>
<idno type="wicri:Area/Main/Curation">004E72</idno>
<idno type="wicri:Area/Main/Exploration">004E72</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Inhaler competence in asthma: Common errors, barriers to use and recommended solutions</title>
<author><name sortKey="Price, D" sort="Price, D" uniqKey="Price D" first="D." last="Price">D. Price</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Academic Primary Care, University of Aberdeen</s1>
<s2>Foresterhill, Aberdeen AB25 2ZD</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Foresterhill, Aberdeen AB25 2ZD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bosnic Anticevich, S" sort="Bosnic Anticevich, S" uniqKey="Bosnic Anticevich S" first="S." last="Bosnic-Anticevich">S. Bosnic-Anticevich</name>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Faculty of Pharmacy, The University of Sydney</s1>
<s2>Sydney, New South Wales</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
<author><name sortKey="Briggs, A" sort="Briggs, A" uniqKey="Briggs A" first="A." last="Briggs">A. Briggs</name>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Health Economics & Health Technology Assessment, University of Glasgow</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Glasgow</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université de Glasgow</orgName>
</affiliation>
</author>
<author><name sortKey="Chrystyn, H" sort="Chrystyn, H" uniqKey="Chrystyn H" first="H." last="Chrystyn">H. Chrystyn</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Division of Pharmacy and Pharmaceutical Sciences, University of Huddersfield</s1>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Division of Pharmacy and Pharmaceutical Sciences, University of Huddersfield</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rand, C" sort="Rand, C" uniqKey="Rand C" first="C." last="Rand">C. Rand</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Medicine, Johns Hopkins University</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Baltimore, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Scheuch, G" sort="Scheuch, G" uniqKey="Scheuch G" first="G." last="Scheuch">G. Scheuch</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Activoero GmbH</s1>
<s2>Gemünden</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Gemünden</wicri:noRegion>
<wicri:noRegion>Activoero GmbH</wicri:noRegion>
<wicri:noRegion>Activoero GmbH</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bousquet, J" sort="Bousquet, J" uniqKey="Bousquet J" first="J." last="Bousquet">J. Bousquet</name>
<affiliation wicri:level="3"><inist:fA14 i1="07"><s1>Hôpital Arnaud de Villeneuve</s1>
<s2>Montpellier</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Montpellier</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Respiratory medicine</title>
<title level="j" type="abbreviated">Respir. med.</title>
<idno type="ISSN">0954-6111</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Respiratory medicine</title>
<title level="j" type="abbreviated">Respir. med.</title>
<idno type="ISSN">0954-6111</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Asthma</term>
<term>Barrier</term>
<term>Chronic</term>
<term>Chronic obstructive pulmonary disease</term>
<term>Error</term>
<term>Inhaler</term>
<term>Obstructive pulmonary disease</term>
<term>Pneumology</term>
<term>Solution</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Asthme</term>
<term>Bronchopneumopathie chronique obstructive</term>
<term>Bronchopneumopathie obstructive</term>
<term>Inhalateur</term>
<term>Erreur</term>
<term>Barrière</term>
<term>Solution</term>
<term>Chronique</term>
<term>Pneumologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Whilst the inhaled route is the first line administration method in the management of asthma, it is well documented that patients can have problems adopting the correct inhaler technique and thus receiving adequate medication. This applies equally to metered dose inhalers and dry powder inhalers and leads to poor disease control and increased healthcare costs. Reviews have highlighted these problems and the recent European Consensus Statement developed a call to action to seek solutions. This review takes forward the challenge of inhaler competence by highlighting the issues and suggesting potential solutions to these problems. The opportunity for technological innovation and educational interventions to reduce errors is highlighted, as well as the specific challenges faced by children. This review is intended as a policy document, as most issues faced by patients have not changed for half a century, and this situation should not be allowed to continue any longer. Future direction with respect to research, policy needs and practice, together with education requirements in inhaler technique are described.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Languedoc-Roussillon</li>
<li>Nouvelle-Galles du Sud</li>
<li>Occitanie (région administrative)</li>
<li>Écosse</li>
</region>
<settlement><li>Glasgow</li>
<li>Montpellier</li>
<li>Sydney</li>
</settlement>
<orgName><li>Université de Glasgow</li>
<li>Université de Sydney</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Price, D" sort="Price, D" uniqKey="Price D" first="D." last="Price">D. Price</name>
</noRegion>
<name sortKey="Briggs, A" sort="Briggs, A" uniqKey="Briggs A" first="A." last="Briggs">A. Briggs</name>
<name sortKey="Chrystyn, H" sort="Chrystyn, H" uniqKey="Chrystyn H" first="H." last="Chrystyn">H. Chrystyn</name>
</country>
<country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Bosnic Anticevich, S" sort="Bosnic Anticevich, S" uniqKey="Bosnic Anticevich S" first="S." last="Bosnic-Anticevich">S. Bosnic-Anticevich</name>
</region>
</country>
<country name="États-Unis"><noRegion><name sortKey="Rand, C" sort="Rand, C" uniqKey="Rand C" first="C." last="Rand">C. Rand</name>
</noRegion>
</country>
<country name="Allemagne"><noRegion><name sortKey="Scheuch, G" sort="Scheuch, G" uniqKey="Scheuch G" first="G." last="Scheuch">G. Scheuch</name>
</noRegion>
</country>
<country name="France"><region name="Occitanie (région administrative)"><name sortKey="Bousquet, J" sort="Bousquet, J" uniqKey="Bousquet J" first="J." last="Bousquet">J. Bousquet</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E72 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E72 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:13-0060161
   |texte=   Inhaler competence in asthma: Common errors, barriers to use and recommended solutions
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Inhaler competence in asthma: Common errors, barriers to use and recommended solutions

Inhaler competence in asthma: Common errors, barriers to use and recommended solutions

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri